Betotastine besilate. Antihistamine, antiallergic

Drugs of the Future

Volumn 23, Issue 3, 1998, Pages 256-260

  Graul, A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; BETOTASTINE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ALLERGY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; ORAL DRUG ADMINISTRATION; POLYMERIZATION; SEDATION; STEREOCHEMISTRY;

EID: 2642692696     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.03.448876     Document Type: Article

References (17)

1. Koda, A., Kuroki, Y., Fujiwara, H., Takamura, S., Yamano, K. (Ube Ind., Ltd.). Piperidine and piperazine derivs., process for preparing the same and pharmaceutical compsns. containing them. EP 335586, JP 89242574, JP 90025465, JP 93294929, US 4929618.
2. Yato, N., Murata, T., Saito, N., Sakai, A., Kikuchi, M., Tsuzurahara, K., Narita, H. Anti-allergic activity of betotastine besilate (TAU-284), a new anti-allergic drug. Folia Pharmacol Jpn 1997, 110(1): 19-29.
3. Matsubara, S., Ono, C., Yamazaki, N., Kashiyama, N., Kikkawa, H., Kikuchi, M., Naito, K., Ikezawa, K. Effect of betotastine besilate (TAU-284) on experimental asthma model in guinea pigs. Jpn Pharmacol Ther 1997, 25(4): 31-6.
4. Sakamoto, O., Okanari, E., Ueno, H. Effect of betotastine on experimental asthma induced in guinea pigs. Jpn Pharmacol Ther 1997, 25(4): 19-24.
5. Honda, H., Murata, K., Hamazaki, A., Sakamoto, O., Ueno, H., Fujiwara, H. Inhibitory effect of betotastine on anaphylactic and histamine-induced reactions in guinea pigs. Jpn Pharmacol Ther 1997, 25(4): 9-18.
6. Matsubara, S., Ono, C., Yamazaki, N., Kashiyama, N., Kikkawa, H., Kikuchi, M., Naito, K., Ikezawa, K. Inhibitory effects of betotastine, a novel anti-allergic drug on histamine-induced bronchoconstriction in anesthetized dogs. Jpn Pharmacol Ther 1997, 25(4): 25-30.
7. Sakai, A., Kikuchi, M., Yato, N., Kikkawa, S., Saito, N., Narita, H. Inhibitory effect of betotastine besilate on antigen-induced airway eosinophil infiltration and peripheral blood eosinophilia in mice. Arzneim-Forsch-Drug Res 1997, 47: 954-8.
8. Murata, T., Matsumoto, Y., Suzuki, T., Naito, K., Takata, I., Tsuzurahara, K. Effect of betotastine besilate (TAU-284), a novel anti-allergic agent, on experimental allergic rhinitis. Jpn J Allergol 1997, 46: 576-84.
9. Kato, M., Nishida, A., Aga, Y., Kita, J., Kudo, Y., Narita, H., Endo, T. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate. Arzneim-Forsch-Drug Res 1997, 47: 1116-24.
10. Narita, H., Kikuchi, M., Asahi, T. et al. General pharmacology of betotastine besilate (TAU-284). Jpn Pharmacol Ther 1997, 25(4): 37-54.
11. Ohashi, R., Tsukimoto, M., Nakamura, S., Ohtsuka, M., Hayashi, K., Nishiyama, S., Hanawa, S., Mitsugi, K., Esumi, Y. Pharmacokinetic studies of betotastine besilate (TAU-284) (I): Absorption, distribution, metabolism and excretion after a single oral administration. Xenobiotic Metab Dispos 1997, 12: 417-38.
12. Tsukimoto, M., Ohashi, R., Nakamura, S., Ohtsuka, M., Hayashi, K., Nishiyama, S., Hanawa, S., Mitsugi, K., Esumi, Y. Pharmacokinetic studies of betotastine besilate (TAU-284) (II): Distribution and excretion after repeated oral administration, and transfer into the fetus and milk of rats. Xenobiotic Metab Dispos 1997, 12: 439-59.
13. Koguchi, A., Kawai, Y., Suetake, K., Ohta, H., Hamamura, M. A 4-week and a 26-week repeated oral toxicity studies of betotastine besilate in rats. Pharmacometrics 1997, 53: 299-318.
14. Koguchi, A., Kawai, Y., Ichiki, T., Ogata, H., Kuwasaki, E., Masunaga, A. A 4-week and a 26-week repeated oral toxicity studies of betotastine besilate in dogs. Pharmacometrics 1997, 53: 319-26.
15. Nishida, A., Asano, Y., Hori, M., Izumi, H., Kimura, E., Yoshinaga, K., Fuchigami, K. Reproductive toxicity studies of betotastine besilate in rats and rabbits. Pharmacometrics 1997, 53: 327-49.
16. Tanabe Seiyaku Annual Report 1997.
17. TAU-284 development status. Tanabe Seiyaku Company Communication February 23, 1998.